オンライン カジノ ブラック ジャックeloper for muscular dystrophy PTC Therapeutics establishes corporation in Tokyo

Mar 27, 2017

オンライン カジノ ブラック ジャックerapeutics Inc.オンライン カジノ ブラック ジャックerapeutics Inc.External site: a new window will open., a US company engaged in development, manufacturing and sales of a drug for muscular dystrophy (MD), established オンライン カジノ ブラック ジャックerapeutics Japan in August, 2015. Muscular dystrophy is a genetic disorder that causes necrosis of skeletal muscles. Designating it a difficult-to-treat disease, the Japanese government provides support for the development of therapeutic drugs for the disease. オンライン カジノ ブラック ジャックerapeutics's drug for MD has obtained marketing certification in Europe and it is already in the process of marketing certification procedures in Japan.


For the establishment of オンライン カジノ ブラック ジャックerapeutics' subsidiary in Japan, theJETRO オンライン ブラック ジャックn Business Support Center (IBSC) provided information on approval and the certification system related to pharmaceuticals in Japan.

Contact Us

Investing in and collaborating with Japan

We will do our very best to support your business expansion into and within Japan as well as business collaboration with Japanese companies. Please feel free to contact us via the form below for any inquiries.

カジノ 無料 ゲーム アプリ

JETRO Worldwide

Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.

ハイパーブラックジャックorldwide